MedPath

Study on comparing the effectiveness of pericapsular nerve group block between ropivacaine and ropivacaine with dexmedetomidine in patients with hip fractures.

Not Applicable
Conditions
Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system
Registration Number
CTRI/2023/12/060779
Lead Sponsor
Dr k. Jeyanthi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients belonging to ASA grade 1,2 and 3 with hip fractures, posted for surgery under spinal anaesthesia who are unable to sit due to pain in the hip joint.

Patients of either sex above 18 years of age.

Exclusion Criteria

Patients with hemorrhagic diasthesis, neurocognitive disorders,spinal deformities, psychiatric disorders.

Patients with allergy to study drug.

Patients with polytrauma, infection over injected site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath